Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 1.1T | 1.1T | 1.1T | 1.0T |
Cost of revenue | 976.9B | 1.0T | 997.4B | 931.1B |
Gross profit | 148.6B | 50.5B | 134.3B | 96.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 61.6B | -23.2B | 65.0B | 61.6B |
Operating income | 77.9B | 63.5B | 57.2B | 27.4B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 7.6B | 8.8B | 8.6B | 9.2B |
Other income expense | — | — | — | — |
Pretax income | 88.7B | 59.0B | 53.3B | 30.9B |
Tax provision | 20.3B | 15.0B | 15.3B | 8.0B |
Net income | 68.4B | 43.9B | 38.1B | 23.0B |
Basic EPS | 16.0 | — | 8.9 | 5.4 |
Diluted EPS | 16.0 | — | 8.9 | 5.4 |
Basic average shares | 4.3B | — | 4.3B | 4.3B |
Diluted average shares | 4.3B | — | 4.3B | 4.3B |
EBITDA | 97.0B | 69.5B | 62.5B | 40.9B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |